Venture Capital Investors

UroGen Pharma

VC investing group UroGen Pharma backs innovative tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated -- because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/1/2026

Transaction History

Our records indicate that UroGen Pharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Liz Barrett

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

UroGen Pharma has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Urbana Corporation | US Fertility

Share this article

About Our VC & M&A Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary